The New Playbook: Building AI-Native Companies in Health & Pharma Tech
AI is reshaping how healthcare companies are built — from how teams are structured, to how products are developed, and how enterprise deals get closed.
Join Define Ventures, JP Morgan, and Perkins Coie for an evening of light refreshments, networking, and a candid conversation on what it takes to build and scale AI-native companies in healthcare and life sciences today. Featured speakers include:
Frank Williams, Venture Partner at Define; former CEO at Evolent Health and The Advisory Board
Christine Lemke, CEO at GXL AI; Former CEO of Evidation Health
Dr. Michael Han, CMO at Ambience Healthcare; Former CMIO at MultiCare Health System
This is an invite-only event for a curated group of entrepreneurs, operators, and strategics building at the intersection of AI and healthcare. There is limited capacity and the location will be shared with registered attendees. We look forward to hearing from you!
***
Define Ventures: With ~$800M AUM and over $20B in exited market value, Define Ventures is the largest early stage VC focused on health and pharma tech. We partner with entrepreneurs from ideation phase to Series B to redefine healthcare.